Basit öğe kaydını göster

dc.contributor.authorDURAL, O
dc.contributor.authorKANBAK, M
dc.contributor.authorCILIV, G
dc.contributor.authorAYPAR, U
dc.contributor.authorERDEM, K
dc.date.accessioned2019-12-12T06:40:15Z
dc.date.available2019-12-12T06:40:15Z
dc.date.issued1995
dc.identifier.issn0310-057X
dc.identifier.urihttps://doi.org/10.1177/0310057X9502300206
dc.identifier.urihttp://hdl.handle.net/11655/16516
dc.description.abstractThe kidney effects of halothane, enflurane and isoflurane were evaluated by using the ratio of urinary excretion of alanine aminopeptidase (AAP) to urine creatinine. Thirty patients in ASA class 1 or 2 were studied, None had renal disease nor received nephrotoxic drugs. Groups 1, 2 and 3 received halothane, enflurane and isoflurane respectively, Creatinine and AAP activities in urine spot tests, serum creatinine and BUN levels were determined preoperatively and on the first and second postoperative days. Urine AAP activity and AAP/urine creatinine values increased significantly on the first and second postoperative days compared with the preoperative values in all groups (P < 0.05). The present study did not reveal any significant difference in the kidney effects of halothane, enflurane and isoflurane through AAP/creatinine in spot urine values.
dc.language.isoen
dc.publisherAustralian Soc Anaesthetists
dc.relation.isversionof10.1177/0310057X9502300206
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnesthesiology
dc.subjectGeneral & Internal Medicine
dc.titleComparison Of Halothane, Enflurane And Isoflurane Kidney Effects Through Alanine Aminopeptidase Urine Creatinine Values
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAnaesthesia And Intensive Care
dc.contributor.departmentAnesteziyoloji ve Reanimasyon
dc.identifier.volume23
dc.identifier.issue2
dc.identifier.startpage162
dc.identifier.endpage164
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster